

Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.
You can purchase shares of Intelligent Bio Solutions (NASDAQ:INBS) through any online brokerage.
Other companies in Intelligent Bio Solutions’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
There is no analysis for Intelligent Bio Solutions to provide a consensus price target.
The stock price for Intelligent Bio Solutions (NASDAQ: INBS) is $1.76 last updated October 30, 2026 at 3:22 AM EDT.
There are no upcoming dividends for Intelligent Bio Solutions.
Intelligent Bio Solutions does not have any upcoming earnings scheduled.
There is no upcoming split for Intelligent Bio Solutions.
Intelligent Bio Solutions is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of...